President Donald Trump’s One Big Beautiful Bill Act, sprawling legislation to extend his tax cuts and enact much of his ...

PatientPoint’s Project Futurama featured discussions on staying relevant in a digital age dominated by virtual healthcare and ...

The new members of the Advisory Committee on Immunization Practices began their tenure Wednesday by shifting the posture of ...

Nearly seven months after the fatal shooting of an insurance CEO in New York drew widespread attention to health insurers’ ...

Millions of people are expected to lose access to Medicaid and Affordable Care Act marketplace health insurance plans if federal lawmakers approve the One Big Beautiful Bill Act, President Donald ...

The long-term health care industry is facing a double whammy from President Donald Trump’s crackdown on immigrants and the ...

Yet despite the increased efforts from various health brands to raise awareness around menopause, both HCPs and patients ...

California lawmakers are poised to delay the state’s much-ballyhooed new law mandating in vitro fertilization insurance coverage for millions, set to take effect July 1.

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

GOP lawmakers want to nationalize Medicaid work requirements to offset Trump’s proposed tax cuts. Yet Georgia’s example shows that this could threaten health care for nearly 16 million Americans and ...

What does it take to secure, plan and execute a main stage presentation at Cannes?